Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Filings indexed 908 across all filing types
Latest filing 2022-09-06 Regulatory Filings
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - MVP 4 pages 24.2KB
Regulatory Filings Classification · 95% confidence The document is a notification about the cessation of securities, specifically options that have expired without exercise or conversion. It provides details about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement related to changes in the company's issued capital securities but does not describe a new share issue or capital increase. It is not a full financial report, earnings release, or management report. It is a regulatory announcement about securities cessation, which fits best under Regulatory Filings (RNS) as it does not fit the more specific categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS). The document length is short and focused on a specific regulatory disclosure about securities cessation.
2022-09-06 English
Change of Director's Interest Notice 2 pages 154.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including shares and options acquired, disposed, and held before and after the change. The content focuses on personal share transactions by a company director, which aligns with insider trading disclosures. The document length is 3056 characters, which is typical for such notices. There is no financial performance data, audit information, or report publication announcement. Therefore, this document fits the category of Director's Dealing (DIRS).
2022-09-06 English
Change of Director's Interest Notice 2 pages 165.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares and options acquired, disposed, and held after the change. The document is a formal notification of insider share transactions by a company director. It does not contain financial statements, earnings data, or management discussion. The content matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3253 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is DIRS (Director's Dealing).
2022-09-05 English
Change of Director's Interest Notice 2 pages 126.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares and options acquired, disposed, and held after the change. The content focuses on personal share transactions by a company director. The document length is 3090 characters, which is relatively short and consistent with a director's dealing notice rather than a full financial report or other filings. Therefore, this document fits the definition of 'Director's Dealing' (DIRS).
2022-09-05 English
Change of Director's Interest Notice 2 pages 156.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares and options acquired, disposed, and held after the change. The document is a formal notification of a director's personal share transactions. It does not contain financial statements, earnings data, or management discussion. It is not an annual report, earnings release, or any other financial report. The content matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3015 characters, which is consistent with a notice rather than a full report. Therefore, the correct classification is DIRS.
2022-09-04 English
Change of Director's Interest Notice 2 pages 154.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including shares and options acquired, disposed, and held before and after the change. The document is a formal notification of a director's personal share transactions. It does not contain financial statements, management discussion, or other report content. The document length is 3056 characters, which is consistent with a notice rather than a full report. Therefore, this document fits the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2022-09-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.